Brand Name(s): Zantac Oral; Zantac AR; Tritec
CAS nº: 66357-35-5
(ra nye' te deen)

About Ranitidine

This new site is dedicated exclusively to ranitidine.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumers or pharma industry professionals, you can now find out everything you need to know about ranitidine, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total ranitidine experience! 

Why is this medication prescribed?

Ranitidine is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Ranitidine also treats gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn.

Ranitidine is in a group of drugs called histamine-2 blockers. Ranitidine works by reducing the amount of acid your stomach produces.

Ranitidine is currently marketed by GlaxoSmithKline under the trade name Zantac®.

See more Product Info

Latest News

Boehringer Ingelheim Initiates Recalls

Boehringer Ingelheim recalled 2.2 million Zantac tablets last month because the drug exceeded...

[more]

Cypress Pharma, Glaxo Unit Reach Settlement Over Generic Version of Glaxo's Zantac Syrup

Drug developer Cypress Pharmaceutical Inc. said Friday it reached a settlement with a unit of...

[more]

Dr Reddy's gets US nod for ulcer drug

Pharma major, Dr Reddy's Laboratory, on Thursday said it has got the approval of US Food and Drug...

[more]

Acid blockers may boost cognitive risk

A U.S. report says long-term use of stomach acid blockers such as Pepcid and Zantac may be linked...

[more]

Actavis is partner to Germany’s biggest health insurer

Actavis is a preferred partner to Germany’s biggest health insurer Allgemeine Ortskrankenkassen.

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.